Literature DB >> 8403634

Septopal beads and autogenous bone grafting for bone defects in patients with chronic osteomyelitis.

M J Patzakis1, K Mazur, J Wilkins, R Sherman, P Holtom.   

Abstract

Thirty-five patients with chronic osteomyelitis were treated with autogenous bone grafts for bone defects. Of 35 patients, two were lost to follow-up evaluation. There were 27 men and six women. The age range was from 18 to 62 years (median age, 29 years). The bones included 22 tibias, nine femurs, and two ulnas. The size of the bone defects ranged from 2.5 x 15 cm (median defect, 2.5 x 6 cm). The length of infection ranged from two to 540 months (median, 31 months). Twenty patients had nonunions and 19 patients required soft-tissue muscle transfers. Patients were treated with systemic antibiotics and/or gentamicin (Septopal) antibiotic beads. Twelve patients were treated with Septopal beads. The range of follow-up evaluation was 24 to 68 months (median, 47 months). Thirty-one of 33 patients had one bone-graft procedure and two patients required two. The time from initial debridement and infection control to bone graft for patients not requiring soft-tissue muscle flaps was one to six weeks (median time, four weeks). For patients requiring soft-tissue muscle transfer, the range was six to nine weeks (median, six weeks). The median time to bone-graft incorporation was six months. All fractures united. Complications included two refractures from auto accidents in the immediate postoperative period, one partial muscle loss, one skin-graft loss, four pin tract draining sites, and two antibiotic-related skin rashes. There was one recurrent infection, and the infection arrest rate was 97%.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8403634

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  16 in total

1.  Cierny-Mader Type III chronic osteomyelitis: the results of patients treated with debridement, irrigation, vancomycin beads and systemic antibiotics.

Authors:  Hakan Kinik; Mert Karaduman
Journal:  Int Orthop       Date:  2007-03-21       Impact factor: 3.075

Review 2.  Biomaterials approaches to treating implant-associated osteomyelitis.

Authors:  Jason A Inzana; Edward M Schwarz; Stephen L Kates; Hani A Awad
Journal:  Biomaterials       Date:  2015-12-18       Impact factor: 12.479

Review 3.  [Local antibiotic therapy].

Authors:  Klaus-Dieter Kühn; Nora Renz; Andrej Trampuz
Journal:  Unfallchirurg       Date:  2017-07       Impact factor: 1.000

4.  Treatment of osteomyelitis in rats by injection of degradable polymer releasing gentamicin.

Authors:  Yaron S Brin; Jacob Golenser; Boaz Mizrahi; Guy Maoz; Abraham J Domb; Shyamal Peddada; Shmuel Tuvia; Abraham Nyska; Meir Nyska
Journal:  J Control Release       Date:  2008-07-20       Impact factor: 9.776

5.  Lipid-based slow-release formulation of amikacin sulfate reduces foreign body-associated infections in mice.

Authors:  A A Roehrborn; J F Hansbrough; B Gualdoni; S Kim
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

6.  Implant-related infection in the tibia: surgical revision strategy with vancomycin cement.

Authors:  Yong-Qing Xu; Yue-Liang Zhu; Xin-Yv Fan; Tao Jin; Yang Li; Xiao-Qing He
Journal:  ScientificWorldJournal       Date:  2014-11-05

7.  Self-mixed antibiotic bone cement: western countries learn from developing countries.

Authors:  Geert H I M Walenkamp
Journal:  Acta Orthop       Date:  2009-10       Impact factor: 3.717

Review 8.  Management of critical-sized bone defects in the treatment of fracture-related infection: a systematic review and pooled analysis.

Authors:  H Bezstarosti; W J Metsemakers; E M M van Lieshout; L W Voskamp; K Kortram; M A McNally; L C Marais; M H J Verhofstad
Journal:  Arch Orthop Trauma Surg       Date:  2020-08-29       Impact factor: 3.067

9.  A new type of biphasic calcium phosphate cement as a gentamicin carrier for osteomyelitis.

Authors:  Wen-Yu Su; Yu-Chun Chen; Feng-Huei Lin
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-09       Impact factor: 2.629

10.  Efficacy of vancomycin-releasing biodegradable poly(lactide-co-glycolide) antibiotics beads for treatment of experimental bone infection due to Staphylococcus aureus.

Authors:  Steve W N Ueng; Song-Shu Lin; I-Chun Wang; Chuen-Yung Yang; Ru-Chin Cheng; Shih-Jung Liu; Err-Cheng Chan; Cheng-Fen Lai; Li-Jen Yuan; Sheng-Chieh Chan
Journal:  J Orthop Surg Res       Date:  2016-04-27       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.